Literature DB >> 25967231

A Novel Catastrophic Presentation of X-Linked Adrenoleukodystrophy.

M M Vawter-Lee1, B E Hallinan2, T A Burrow3, C G Spaeth3, T M Arthur2.   

Abstract

OBJECTIVE: We report a novel presentation of childhood cerebral X-linked adrenoleukodystrophy: status epilepticus followed by abrupt and catastrophic neurologic deterioration.
METHODS: A description of the clinical presentation, laboratory evaluation, and imaging findings leading to a diagnosis of X-linked adrenoleukodystrophy.
RESULTS: A 3-year-old male with prior history of autism presented with fever, diarrhea, and status epilepticus requiring a pentobarbital coma. Admission labs were notable only for a glucose level of 22 mg/dL, which stabilized after correction. The child never returned to his prior neurologic baseline, with complete loss of gross motor, fine motor, and speech skills. Serial brain magnetic resonance imaging (MRI)/magnetic resonance spectroscopy (MRS) was notable for progressive diffuse cortical signal changes with swelling, diffusion restriction, and ultimately laminar necrosis. Nine months after presentation, CSF (cerebrospinal fluid) protein and MRS lactate were persistently elevated, concerning for a neurodegenerative disorder. This led to testing for mitochondrial disease, followed by lysosomal and peroxisomal disorders. Very long-chain fatty acids were elevated. Identification of a pathogenic ABCD1 mutation confirmed the diagnosis of X-linked adrenoleukodystrophy.
CONCLUSIONS: Boys with childhood cerebral X-linked adrenoleukodystrophy typically present with gradual behavioral changes. Rare reports of boys presenting with transient altered mental status or status epilepticus describe a recovery to their pre-presentation baseline. To our knowledge this is the first X-ALD patient to present with status epilepticus with abrupt and catastrophic loss of neurologic function. X-linked adrenoleukodystrophy should be suspected in young males presenting with seizures, acute decline in neurologic function, with persistently elevated CSF protein and MRS lactate.

Entities:  

Year:  2015        PMID: 25967231      PMCID: PMC4582021          DOI: 10.1007/8904_2015_446

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  8 in total

1.  Coma as an acute presentation of adrenoleukodystrophy.

Authors:  S Ravid; A S Diamond; L Eviatar
Journal:  Pediatr Neurol       Date:  2000-03       Impact factor: 3.372

2.  Epileptic seizures and electroencephalographic evolution in genetic leukodystrophies.

Authors:  P J Wang; W L Hwu; Y Z Shen
Journal:  J Clin Neurophysiol       Date:  2001-01       Impact factor: 2.177

3.  Acute presentation of childhood adrenoleukodystrophy.

Authors:  D J Stephenson; L Bezman; G V Raymond
Journal:  Neuropediatrics       Date:  2000-12       Impact factor: 1.947

4.  Unilateral cortical necrosis following status epilepticus with hypoglycemia.

Authors:  Florence J C Christiaens; Leena D Mewasingh; Catherine Christophe; Serge Goldman; Bernard Dan
Journal:  Brain Dev       Date:  2003-03       Impact factor: 1.961

5.  Acute onset of X-linked adrenoleukodystrophy mimicking encephalitis.

Authors:  E Zammarchi; M A Donati; F Tucci; C Fonda; F Fanelli; R Pazzaglia
Journal:  Brain Dev       Date:  1994 May-Jun       Impact factor: 1.961

6.  Frequency and patterns of MRI abnormalities due to status epilepticus.

Authors:  Tracey A Milligan; Amir Zamani; Edward Bromfield
Journal:  Seizure       Date:  2008-08-23       Impact factor: 3.184

7.  Periictal magnetic resonance imaging in status epilepticus.

Authors:  Yen-Chu Huang; Hsu-Huei Weng; Yu-tai Tsai; Ying-Chih Huang; Ming-Chang Hsiao; Chih-Ying Wu; Ya-Hui Lin; Huan-Lin Hsu; Jiann-Der Lee
Journal:  Epilepsy Res       Date:  2009-06-21       Impact factor: 3.045

8.  X-linked adrenoleukodystrophy (X-ALD): clinical presentation and guidelines for diagnosis, follow-up and management.

Authors:  Marc Engelen; Stephan Kemp; Marianne de Visser; Björn M van Geel; Ronald J A Wanders; Patrick Aubourg; Bwee Tien Poll-The
Journal:  Orphanet J Rare Dis       Date:  2012-08-13       Impact factor: 4.123

  8 in total
  3 in total

1.  In vivo gene editing via homology-independent targeted integration for adrenoleukodystrophy treatment.

Authors:  Sung-Ah Hong; Jung Hwa Seo; Soohyun Wi; Eul Sik Jung; Jihyeon Yu; Gue-Ho Hwang; Ji Hea Yu; Ahreum Baek; Soeon Park; Sangsu Bae; Sung-Rae Cho
Journal:  Mol Ther       Date:  2021-05-29       Impact factor: 11.454

2.  Neurodegeneration in a Drosophila model of adrenoleukodystrophy: the roles of the Bubblegum and Double bubble acyl-CoA synthetases.

Authors:  Anna Sivachenko; Hannah B Gordon; Suzanne S Kimball; Erin J Gavin; Joshua L Bonkowsky; Anthea Letsou
Journal:  Dis Model Mech       Date:  2016-02-18       Impact factor: 5.758

3.  Etiology and treatment of adrenoleukodystrophy: new insights from Drosophila.

Authors:  Hannah B Gordon; Lourdes Valdez; Anthea Letsou
Journal:  Dis Model Mech       Date:  2018-06-15       Impact factor: 5.758

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.